Bumper Offer - Urjas oil Just @ Rs. 1
Ritecef O 200 Tablet DT is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Urinary Tract Infection, Gonorrhea, Meningitis. Secondary and off-label uses of Ritecef O 200 Tablet DT have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Ritecef O 200 Tablet DT. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Ritecef O 200 Tablet DT side effects, there are can be others also. These have been listed below. Such side effects of Ritecef O 200 Tablet DT normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Ritecef O 200 Tablet DT's effect is Safe during pregnancy and Mild for lactating mothers. In addition, Ritecef O 200 Tablet DT's effects on the liver, heart and kidney are discussed below in the Ritecef O 200 Tablet DT related warnings section.
Ritecef O 200 Tablet DT is not recommended if you suffer from certain medical conditions as it can have adverse effects. Jaundice, Drug Allergy are examples of such conditions. The section on Ritecef O 200 Tablet DT contraindications lists all such conditions.
Drug interactions for Ritecef O 200 Tablet DT have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Ritecef O 200 Tablet DT is not safe while driving, and is is not addictive in nature.
Ritecef O 200 Tablet DT is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Ritecef O 200 Tablet DT is used -
Severe
Mild
Is the use of Ritecef O 200 Tablet DT safe for pregnant women?
Pregnant women can take Ritecef safely.
Is the use of Ritecef O 200 Tablet DT safe during breastfeeding?
Side effects of Ritecef for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Ritecef O 200 Tablet DT on the Kidneys?
Ritecef has very mild side effects on the kidneys.
What is the effect of Ritecef O 200 Tablet DT on the Liver?
Ritecef may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Ritecef O 200 Tablet DT on the Heart?
There are no any side effects of Ritecef for the heart.
Ritecef O 200 Tablet DT should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ritecef O 200 Tablet DT unless your doctor advises you to do so -
Is this Ritecef O 200 Tablet DT habit forming or addictive?
Ritecef O 200 Tablet DT does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ritecef O 200 Tablet DT you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Ritecef O 200 Tablet DT should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Ritecef O 200 Tablet DT is not used to treat mental disorders.
Interaction between Food and Ritecef O 200 Tablet DT
It is safe to take Ritecef O 200 Tablet DT with food.
Interaction between Alcohol and Ritecef O 200 Tablet DT
Due to lack of research, there is no information about the side effects of taking Ritecef O 200 Tablet DT with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
